Condition: Opioid Use Disorder · Chronic Pain · Methadone · Sponsor: University of Maryland, Baltimore
This study will evaluate whether once versus twice daily dosing of methadone will be an effective method for managing comorbid pain and opioid use disorder.
This description comes directly from the study's public registry record.
Kelly E Dunn, PhD, M.B.A. · 802-922-1682 · kelly.dunn@som.umaryland.edu
Always discuss trial participation with your own doctor first.
| Addiction Treatment Services (ATS) | Baltimore, Maryland, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05459402